CIK 0000897448
- Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- Operating
- Phone
- +353 16699020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-01 | Ketchum Steven B EVP, Chief Scientific Officer | Option exercise | +3,688 | 44,567 | ||
| 2026-07-01 | Ketchum Steven B EVP, Chief Scientific Officer | Shares withheld for taxes | −1,887 | $15.94 | $30K | 42,680 |
| 2026-07-01 | Ketchum Steven B EVP, Chief Scientific Officer | Grant or award · Restricted Stock Unit | +3,688 | 0 | ||
| 2026-02-01 | Ketchum Steven B EVP, Chief Scientific Officer | Grant or award · Restricted Stock Unit | +8,013 | 8,013 | ||
| 2026-02-01 | Ketchum Steven B EVP, Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +36,060 | 36,060 | ||
| 2026-01-31 | Ketchum Steven B EVP, Chief Scientific Officer | Option exercise | +2,246 | 41,243 | ||
| 2026-01-31 | Ketchum Steven B EVP, Chief Scientific Officer | Shares withheld for taxes | −1,235 | $15.42 | $19K | 40,008 |
| 2026-01-31 | Ketchum Steven B EVP, Chief Scientific Officer | Option exercise | +1,933 | 41,941 | ||
| 2026-01-31 | Ketchum Steven B EVP, Chief Scientific Officer | Shares withheld for taxes | −1,062 | $15.42 | $16K | 40,879 |
| 2026-01-31 | Ketchum Steven B EVP, Chief Scientific Officer | Option exercise · Restricted Stock Unit | +2,246 | 0 | ||
| 2026-01-31 | Ketchum Steven B EVP, Chief Scientific Officer | Option exercise · Restricted Stock Unit | +1,933 | 1,933 | ||
| 2026-01-02 | Ketchum Steven B EVP, Chief Scientific Officer | Option exercise | +3,688 | 41,038 | ||
| 2026-01-02 | Ketchum Steven B EVP, Chief Scientific Officer | Shares withheld for taxes | −2,041 | $13.96 | $28K | 38,997 |
| 2026-01-02 | Ketchum Steven B EVP, Chief Scientific Officer | Grant or award · Restricted Stock Unit | +3,688 | 3,688 | ||
| 2025-01-31 | Ketchum Steven B Chief Scientific Officer | Option exercise | +34,566 | 728,524 | ||
| 2025-01-31 | Ketchum Steven B Chief Scientific Officer | Shares withheld for taxes | −19,197 | $0.62 | $12K | 709,327 |
| 2025-01-31 | Ketchum Steven B Chief Scientific Officer | Option exercise | +44,933 | 754,260 | ||
| 2025-01-31 | Ketchum Steven B Chief Scientific Officer | Shares withheld for taxes | −24,833 | $0.62 | $15K | 729,427 |
| 2025-01-31 | Ketchum Steven B Chief Scientific Officer | Option exercise | +38,667 | 768,094 | ||
| 2025-01-31 | Ketchum Steven B Chief Scientific Officer | Shares withheld for taxes | −21,093 | $0.62 | $13K | 747,001 |
Page 1 of 20 · 400 trades